Due to their tumor-specific expression, TSAs are attractive targets for therapeutic interventions aimed at stimulating an immune response against cancer cells while sparing healthy tissues, and due to their “non-self” features, they have a higher affinity to MHC molecules and T-cell receptors [27]. This evidence concerns the gene HLA-C and cancer.